Notice of Capital Markets Day

RNS Number : 4402A

Syncona Limited

21 January 2020

 

Syncona Limited

Notice of Capital Markets Day

21 January 2020

Syncona Ltd, a leading healthcare company focused on founding, building and funding global leaders in life sciences, will host a Capital Markets Day for investors and analysts on the afternoon of Tuesday, 4 February 2020 in Central London.

Syncona's management team will present Syncona's strategy and long-term vision for the business. This will be followed by panel discussions with leaders from Syncona's portfolio companies on translating exceptional science, the future of cell therapy, and building a commercial gene therapy platform.

Presentations and panels are taking place from 13:00 - 17:00 GMT. A live webcast of the Capital Markets Day will be made available on the Investor Relations section of the company's website at www.synconaltd.com 

For further information and to register to attend, please contact [e-mail].

[ENDS]

Enquiries

Syncona Ltd

Siobhan Weaver / Annabel Clay 

Tel : [phone]

FTI Consulting

Ben Atwell / Natalie Garland-Collins / Tim Stamper

Tel: [phone]

About Syncona

Syncona is a leading FTSE250 healthcare company focused on founding, building and funding a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio of 15 - 20 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which we are seeking to deliver strong risk-adjusted returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses. We take a long-term view, underpinned by a strategic capital base which provides us with control and flexibility over the management of our portfolio. We focus on delivering dramatic efficacy for patients in areas of high unmet need.

 

END

 

 

MSCVFLBLBFLZBBB